Cite
HARVARD Citation
Gamba, S. et al. (2015). Effect of KRAS exon 2 mutations on antitumor activity of afatinib and gefitinib. Anti-cancer drugs. 26 (4), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gamba, S. et al. (2015). Effect of KRAS exon 2 mutations on antitumor activity of afatinib and gefitinib. Anti-cancer drugs. 26 (4), p. . [Online].